BlackRock, Inc. 13D and 13G filings for Paratek Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2022-07-08 4:57 pm Sale |
2022-06-30 | 13G | Paratek Pharmaceuticals, Inc. PRTK |
BlackRock Inc. BLK |
869,224 1.600% |
-2,108,456 (-70.81%) |
Filing |
| 2022-02-02 7:11 pm Sale |
2021-12-31 | 13G | Paratek Pharmaceuticals, Inc. PRTK |
BlackRock Inc. BLK |
2,977,680 5.900% |
-469,649 (-13.62%) |
Filing |
| 2021-01-29 5:22 pm Purchase |
2020-12-31 | 13G | Paratek Pharmaceuticals, Inc. PRTK |
BlackRock Inc. BLK |
3,447,329 7.600% |
1,123,417 (+48.34%) |
Filing |